<div class='cut-page'><button class='gotoPage' data-page='1'>Page 1</button> <div class='cut-image'><img data-url='document/e-2016-10-11-efr9-l-01-4aq-z-3-cyp2c19-4-a-0-01-a-2-iq.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: 약학정보원 · 2016. 10. 11. · Efr9-l 01 4.aQ.-Z 3) : CYP2C19 4) a 0 01 A. 2. *ÅIQ. l) 01 10) intolerance), Lapp (Lapp lactase deficiency) malabsorption) -SQ-I o OF 2.7%, -qæ' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022081411/60ac9d25cc653a4dcf7b5094/html5/thumbnails/1.jpg' width='140' height='200' /></div></div><div class='cut-page'><button class='gotoPage' data-page='2'>Page 2</button> <div class='cut-image'><img data-url='document/e-2016-10-11-efr9-l-01-4aq-z-3-cyp2c19-4-a-0-01-a-2-iq.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: 약학정보원 · 2016. 10. 11. · Efr9-l 01 4.aQ.-Z 3) : CYP2C19 4) a 0 01 A. 2. *ÅIQ. l) 01 10) intolerance), Lapp (Lapp lactase deficiency) malabsorption) -SQ-I o OF 2.7%, -qæ' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022081411/60ac9d25cc653a4dcf7b5094/html5/thumbnails/2.jpg' width='140' height='200' /></div></div>